01 1Hubei Haosun Pharmaceutical Co., Ltd.
01 1DOCETAXEL ANHYDROUS
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-09-12
Pay. Date : 2019-09-06
DMF Number : 22562
Submission : 2009-02-26
Status : Active
Type : II
20
Hubei Haosun Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is DOCETAXEL ANHYDROUS, with a corresponding US DMF Number 22562.
Remarkably, this DMF maintains an Active status since its submission on February 26, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 12, 2019, and payment made on September 06, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
